- 5,3-AB-CHFUPYCA
- AB-CHFUPYCA
- AB-CHMFUPPYCA
- AMB-CHM5FUPPYZ3CA
- N2-[1-(Cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carbonyl]-L-valinamide
- N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide
Brandt, SD; Kavanagh, PV; Westphal, F; Dreiseitel, W; Dowling, G; Bowden, MJ; Williamson, JPB. Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233 Drug Test. Anal., 16 Aug 2020, 13 (1), 175-196. 2.6 MB. https://doi.org/10.1002/dta.2913 #AB-CHFUPYCA GC,MS,NMR
Alam, RM; Keating, JJ. “Walking the nitrogen around the ring”: Chemical synthesis and spectroscopic characterization of novel 4‐, 5‐, 6‐, and 7‐azaindazole analogs of the synthetic cannabinoid receptor agonist MDMB‐PINACA Drug Test. Anal., 11 Nov 2021, 14 (2), 277-297. 4.1 MB. https://doi.org/10.1002/dta.3180 #6 MS,NMR,IR,UV
McLaughlin, G; Morris, N; Kavanagh, PV; Power, JD; Twamley, B; O'Brien, J; Talbot, B; Dowling, G; Brandt, SD. The synthesis and characterization of the ‘research chemical’ N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer Drug Test. Anal., 1 Sep 2016, 8 (9), 920-929. 1.8 MB. https://doi.org/10.1002/dta.1864 #5,3-AB-CHMFUPPYCA LC,MS,NMR,other